US Stock MarketDetailed Quotes

TLIS Talis Biomedical

Watchlist
  • 1.750
  • -0.150-7.89%
15min DelayTrading Sep 11 10:39 ET
3.19MMarket Cap-62P/E (TTM)

Talis Biomedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
-46.72%73K
-88.72%412K
41.12%151K
-89.59%76K
-90.44%48K
-94.08%137K
3.65M
107K
730K
Operating revenue
--0
-46.72%73K
-88.72%412K
41.12%151K
-89.59%76K
-90.44%48K
-94.08%137K
--3.65M
--107K
--730K
Cost of revenue
0
-70.00%6K
-99.51%41K
-99.66%8K
-99.51%6K
-99.46%7K
-99.43%20K
8.39M
2.33M
1.24M
Gross profit
0
-42.74%67K
107.83%371K
106.43%143K
113.83%70K
105.13%41K
109.69%117K
-4.74M
-2.23M
-506K
Operating expense
-41.71%9.58M
-25.79%14.18M
-39.14%67.19M
-43.61%14.6M
-35.16%17.04M
-37.93%16.43M
-39.82%19.11M
-42.44%110.4M
-9.23%25.89M
-31.59%26.28M
Selling and administrative expenses
24.45%7.98M
82.08%11.65M
-30.73%28.21M
-38.85%6.6M
-0.25%8.8M
-30.16%6.41M
-46.36%6.4M
-3.98%40.73M
-12.34%10.8M
-31.01%8.83M
Research and development costs
-84.83%1.6M
-81.64%2.53M
-42.55%40.69M
-47.24%8.04M
-52.62%8.3M
-39.22%10.56M
-33.36%13.8M
-55.05%70.83M
-10.67%15.24M
-32.20%17.52M
Other operating expenses
----
----
-48.45%-1.72M
70.67%-44K
3.03%-64K
-661.43%-533K
-23.68%-1.08M
85.84%-1.16M
82.52%-150K
69.72%-66K
Operating profit
41.57%-9.58M
25.69%-14.12M
41.97%-66.82M
48.58%-14.46M
36.64%-16.97M
39.90%-16.39M
42.38%-19M
39.97%-115.14M
1.43%-28.11M
30.27%-26.79M
Net non-operating interest income expense
Other net income (expense)
-46.28%729K
-7.20%1.08M
126.05%4.81M
-15.88%996K
68.50%1.29M
417.94%1.36M
1,488.10%1.17M
1,066.82%2.13M
983.58%1.18M
25,600.00%765K
Other non- operating income (expenses)
-46.28%729K
-7.20%1.08M
126.05%4.81M
-15.88%996K
68.50%1.29M
417.94%1.36M
1,488.10%1.17M
1,066.82%2.13M
983.58%1.18M
25,600.00%765K
Income before tax
41.14%-8.85M
26.90%-13.04M
45.13%-62.01M
50.02%-13.46M
39.73%-15.68M
44.34%-15.03M
46.05%-17.83M
41.15%-113.01M
6.02%-26.93M
32.27%-26.02M
Income tax
Net income
41.14%-8.85M
26.90%-13.04M
45.13%-62.01M
50.02%-13.46M
39.73%-15.68M
44.34%-15.03M
46.05%-17.83M
41.15%-113.01M
6.02%-26.93M
32.27%-26.02M
Net income continuous Operations
41.14%-8.85M
26.90%-13.04M
45.13%-62.01M
50.02%-13.46M
39.73%-15.68M
44.34%-15.03M
46.05%-17.83M
41.15%-113.01M
6.02%-26.93M
32.27%-26.02M
Minority interest income
Net income attributable to the parent company
41.14%-8.85M
26.90%-13.04M
45.13%-62.01M
50.02%-13.46M
39.73%-15.68M
44.34%-15.03M
46.05%-17.83M
41.15%-113.01M
6.02%-26.93M
32.27%-26.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
41.14%-8.85M
26.90%-13.04M
45.13%-62.01M
50.02%-13.46M
39.73%-15.68M
44.34%-15.03M
46.05%-17.83M
41.15%-113.01M
6.02%-26.93M
32.27%-26.02M
Basic earnings per share
41.23%-4.86
27.34%-7.15
45.64%-34.12
50.98%-7.39
40.30%-8.62
44.90%-8.27
47.52%-9.84
50.65%-62.77
7.38%-15.0746
35.39%-14.44
Diluted earnings per share
41.23%-4.86
27.34%-7.15
45.64%-34.12
50.98%-7.39
40.30%-8.62
44.90%-8.27
47.52%-9.84
50.65%-62.77
7.38%-15.0746
35.39%-14.44
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0-46.72%73K-88.72%412K41.12%151K-89.59%76K-90.44%48K-94.08%137K3.65M107K730K
Operating revenue --0-46.72%73K-88.72%412K41.12%151K-89.59%76K-90.44%48K-94.08%137K--3.65M--107K--730K
Cost of revenue 0-70.00%6K-99.51%41K-99.66%8K-99.51%6K-99.46%7K-99.43%20K8.39M2.33M1.24M
Gross profit 0-42.74%67K107.83%371K106.43%143K113.83%70K105.13%41K109.69%117K-4.74M-2.23M-506K
Operating expense -41.71%9.58M-25.79%14.18M-39.14%67.19M-43.61%14.6M-35.16%17.04M-37.93%16.43M-39.82%19.11M-42.44%110.4M-9.23%25.89M-31.59%26.28M
Selling and administrative expenses 24.45%7.98M82.08%11.65M-30.73%28.21M-38.85%6.6M-0.25%8.8M-30.16%6.41M-46.36%6.4M-3.98%40.73M-12.34%10.8M-31.01%8.83M
Research and development costs -84.83%1.6M-81.64%2.53M-42.55%40.69M-47.24%8.04M-52.62%8.3M-39.22%10.56M-33.36%13.8M-55.05%70.83M-10.67%15.24M-32.20%17.52M
Other operating expenses ---------48.45%-1.72M70.67%-44K3.03%-64K-661.43%-533K-23.68%-1.08M85.84%-1.16M82.52%-150K69.72%-66K
Operating profit 41.57%-9.58M25.69%-14.12M41.97%-66.82M48.58%-14.46M36.64%-16.97M39.90%-16.39M42.38%-19M39.97%-115.14M1.43%-28.11M30.27%-26.79M
Net non-operating interest income expense
Other net income (expense) -46.28%729K-7.20%1.08M126.05%4.81M-15.88%996K68.50%1.29M417.94%1.36M1,488.10%1.17M1,066.82%2.13M983.58%1.18M25,600.00%765K
Other non- operating income (expenses) -46.28%729K-7.20%1.08M126.05%4.81M-15.88%996K68.50%1.29M417.94%1.36M1,488.10%1.17M1,066.82%2.13M983.58%1.18M25,600.00%765K
Income before tax 41.14%-8.85M26.90%-13.04M45.13%-62.01M50.02%-13.46M39.73%-15.68M44.34%-15.03M46.05%-17.83M41.15%-113.01M6.02%-26.93M32.27%-26.02M
Income tax
Net income 41.14%-8.85M26.90%-13.04M45.13%-62.01M50.02%-13.46M39.73%-15.68M44.34%-15.03M46.05%-17.83M41.15%-113.01M6.02%-26.93M32.27%-26.02M
Net income continuous Operations 41.14%-8.85M26.90%-13.04M45.13%-62.01M50.02%-13.46M39.73%-15.68M44.34%-15.03M46.05%-17.83M41.15%-113.01M6.02%-26.93M32.27%-26.02M
Minority interest income
Net income attributable to the parent company 41.14%-8.85M26.90%-13.04M45.13%-62.01M50.02%-13.46M39.73%-15.68M44.34%-15.03M46.05%-17.83M41.15%-113.01M6.02%-26.93M32.27%-26.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 41.14%-8.85M26.90%-13.04M45.13%-62.01M50.02%-13.46M39.73%-15.68M44.34%-15.03M46.05%-17.83M41.15%-113.01M6.02%-26.93M32.27%-26.02M
Basic earnings per share 41.23%-4.8627.34%-7.1545.64%-34.1250.98%-7.3940.30%-8.6244.90%-8.2747.52%-9.8450.65%-62.777.38%-15.074635.39%-14.44
Diluted earnings per share 41.23%-4.8627.34%-7.1545.64%-34.1250.98%-7.3940.30%-8.6244.90%-8.2747.52%-9.8450.65%-62.777.38%-15.074635.39%-14.44
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-0.06%